
Medicenna receives five IL-2 and IL-4 superkine patents
Medicenna receives five IL-2 and IL-4 superkine patents

Medicenna receives five IL-2 and IL-4 superkine patents
XORTX arranges $114,500 (U.S.) private placement
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Revive Therapeutics arranges financing, debt settlement
Ocumetics wins ethics OK for human lens implant trial
Biomark sets 2025 to 2026 cancer test milestones
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Kane Biotech presents revyve wound care data
CareRx Reports Results for the Second Quarter of 2025
Pharmadrug enters LOI to acquire 40% of Canurta
Netramark Holdings, Pentara form partnership
Conavi sees publication of Novasight system case report
Bausch Health Announces Second Quarter 2025 Results
Mountain Valley MD Provides Business Update, Advances Commercialization Strategies